查看静脉注射脂质体包封的胞壁酰三肽治疗狗骨肉瘤的源代码
←
静脉注射脂质体包封的胞壁酰三肽治疗狗骨肉瘤
跳转到:
导航
,
搜索
因为以下原因,你没有权限编辑本页:
您刚才请求的操作只有这个用户组中的用户才能使用:
用户
您可以查看并复制此页面的源代码:
原文:https://pubmed.ncbi.nlm.nih.gov/2733037/ Published: 1989 == Abstract == 犬骨肉瘤 (osteosarcoma) 是狗的一种自发性恶性肿瘤,其特征是在诊断时微转移至肺和肺外组织。标准治疗包括截肢,但中位生存时间为 3-4 个月,因转移而死亡。进行了一项随机双盲试验,以评估脂质体封装的胞壁酰三肽-磷脂酰乙醇胺(脂质体/MTP-PE)作为治疗因骨肉瘤而截肢的狗的转移。14 只狗接受脂质体/MTP-PE 治疗,13 只狗接受空脂质体治疗。用脂质体/MTP-PE 治疗的狗的中位生存时间为 222 天,而用空脂质体治疗的狗的中位生存时间为 77 天(P 小于 0.002)。在脂质体/MTP-PE治疗组中,仍有四只狗在手术后 1 年以上存活且无转移。治疗耐受性良好。除了注射后 2-6 小时体温轻度升高(1-2 摄氏度)外,没有观察到显着的毒性作用。 Canine osteosarcoma is a spontaneous malignancy in dogs, characterized by micrometastasis to pulmonary and extrapulmonary tissues at the time of diagnosis. Standard treatment involves amputation of the affected leg, but median survival time is 3-4 months with death due to metastasis. A randomized double-blind trial was conducted to evaluate liposome-encapsulated muramyl tripeptide-phosphatidylethanolamine (liposome/MTP-PE) as a treatment for metastasis in dogs undergoing amputation for osteosarcoma. Fourteen dogs were treated with liposome/MTP-PE, and 13 were treated with empty liposomes. Median survival time was 222 days for dogs treated with liposome/MTP-PE, compared to 77 days for dogs treated with empty liposomes (P less than .002). In the liposome/MTP-PE-treated group there were still four dogs alive and free of metastasis at greater than 1 year post surgery. Treatment was well tolerated; no significant toxic effects were noted except for mild elevations in body temperature (1-2 degrees C) for 2-6 hours post injection. <br> == Introduction == <br>
返回到
静脉注射脂质体包封的胞壁酰三肽治疗狗骨肉瘤
。
个人工具
登录
名字空间
页面
讨论
变换
查看
阅读
查看源代码
查看历史
操作
搜索
导航
首页
社区专页
新闻动态
最近更改
随机页面
帮助
工具箱
链入页面
相关更改
特殊页面